Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities

被引:0
|
作者
Li, Jinke [1 ]
Xu, Yawen [1 ]
Han, Yunying [1 ]
Yang, Aifu [1 ]
Qian, Miaoshan [1 ]
Wang, Bo [1 ]
机构
[1] Longnan First Peoples Hosp, Dept Gen Surg, Longnan 746099, Peoples R China
关键词
cancer; immune evasion; SOX family; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; GENE FAMILY; EXPRESSION; MOUSE; SRY; DIFFERENTIATION; PROLIFERATION; CARTILAGE; MEMBER;
D O I
10.1097/MD.0000000000041393
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer immune evasion is one of the important mechanisms for cancer development, which is essential to developing novel immunotherapeutic strategies. The SOX (SRY-related HMG-box) family of transcription factors plays a crucial role in normal physiology as well as in a variety of human diseases especially cancer. It has been shown that SOX is involved in cancer immune evasion processes. This mini-review aimed to summarize how SOX family members induce cancer immune evasion by regulating antigen presentation, shaping the tumor immunosuppressive milieu, and controlling regulatory immune checkpoint inhibitors like programmed death ligand 1. Thorough exploration of SOX family will help uncover the mechanism of cancer immune evasion, and provide new ideas and targets for the development of immunotherapy strategies.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Emerging roles of lncRNA in cancer and therapeutic opportunities
    Jiang, Ming-Chun
    Ni, Jiao-Jiao
    Cui, Wen-Yu
    Wang, Bo-Ya
    Zhuo, Wei
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (07): : 1354 - 1366
  • [32] Integrins in cancer: Emerging mechanisms and therapeutic opportunities
    Liu, Fangfang
    Wu, Qiong
    Dong, Zigang
    Liu, Kangdong
    PHARMACOLOGY & THERAPEUTICS, 2023, 247
  • [33] The role of Fusobacteria in oral cancer and immune evasion
    Harrandah, Amani M.
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (02) : 125 - 131
  • [34] When N7-methyladenosine modification meets cancer: Emerging frontiers and promising therapeutic opportunities
    Du, Dan
    He, Jing
    Ju, Chenxi
    Wang, Chang
    Li, Hongle
    He, Fucheng
    Zhou, Mingxia
    CANCER LETTERS, 2023, 562
  • [35] Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments
    Gupta, Romi
    Kumar, Raj
    Penn, Courtney A.
    Wajapeyee, Narendra
    TRENDS IN IMMUNOLOGY, 2025, 46 (02) : 166 - 181
  • [36] Emerging role of high density lipoproteins as a player in the immune system
    Norata, Giuseppe Danilo
    Pirillo, Angela
    Ammirati, Enrico
    Catapano, Alberico Luigi
    ATHEROSCLEROSIS, 2012, 220 (01) : 11 - 21
  • [37] Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target
    Liu, Guoqiang
    Zhu, Minggang
    Zhang, Mingrui
    Pan, Feng
    CANCERS, 2023, 15 (04)
  • [38] CTHRC1: a key player in colorectal cancer progression and immune evasion
    Chen, Qingjie
    Wang, Haohao
    Liu, Qinghua
    Luo, Changjiang
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [39] Candida albicans biofilms: antifungal resistance, immune evasion, and emerging therapeutic strategies
    Fan, FangMei
    Liu, Yi
    Liu, YiQing
    Lv, RuiXue
    Sun, Wei
    Ding, WenJing
    Cai, YanXing
    Li, WeiWei
    Liu, Xing
    Qu, Wei
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (5-6)
  • [40] Arginase: An emerging and promising therapeutic target for cancer treatment
    Niu, Fanglin
    Yu, Yi
    Li, Zhuozhuo
    Ren, Yuanyuan
    Li, Zi
    Ye, Qiang
    Liu, Ping
    Ji, Chenshuang
    Qian, Lu
    Xiong, Yuyan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149